Clinical Trials Using Anti-CD19/CD3 T-cell Engaging Bispecific Antibody CLN-978
Review the clinical trials studying anti-cd19/cd3 t-cell engaging bispecific antibody cln-978 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.
Trials 1-1 of
1
- Status: ActiveLocation: Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York